Indian equity markets are expected to witness stock-specific action today as investors monitor quarterly earnings, strategic investments, regulatory approvals and fresh business developments announced by several listed companies.
Market participants will also keep an eye on corporate earnings, order wins, partnerships and regulatory clearances, which could influence trading sentiment during today's session.
L&T Technology Services reported a steady performance for the first quarter. Consolidated net profit increased 13% year-on-year to ₹356.6 crore, while revenue rose 11.5% to ₹2,940.1 crore. EBIT climbed 28.1% to ₹461.3 crore, with the EBIT margin expanding to 15.7% from 13.7%, reflecting improved operational efficiency.
Tata Elxsi posted a strong first-quarter performance with net profit rising 18.2% year-on-year to ₹170.6 crore. Revenue also increased 14.5% to ₹1,021.1 crore, indicating healthy business momentum.
Hero MotoCorp's board approved an additional investment of ₹1,000 crore in Ather Energy. Hero MotoCorp currently holds a 29.48% stake in the electric vehicle manufacturer, and the proposed investment is expected to strengthen Ather Energy's growth plans.
Belrise Industries launched its Qualified Institutions Placement (QIP) on 14 July with a floor price of ₹230.79 per share. The company may offer a discount of up to 5% on the floor price to eligible institutional investors.
PDS announced a strategic partnership between its manufacturing business and Indonesia-based Busana Apparel Group. The collaboration is expected to strengthen the company's global manufacturing capabilities and expand its international sourcing network.
Kirloskar Brothers' UK subsidiary, SPP Pumps Ltd., secured an order worth GBP 11.7 million (approximately ₹149.59 crore) from Saipem Offshore Construction SPA for the supply of vertical pumps and spare parts, strengthening its international order book.
The Reserve Bank of India approved Delhivery Financial Services' application for a Certificate of Registration as a Type II NBFC-ND. The approval remains subject to the submission of certain documents to the satisfaction of the RBI.
Read More: India's Vegetable Oil Imports Drop 29% YoY in June 2026 on Reduced Palm Oil Discount!
IOL Chemicals & Pharmaceuticals received approval from China's Centre for Drug Evaluation (CDE) under the National Medical Products Administration for its API product, Clopidogrel Bisulfate. The approval strengthens the company's regulatory portfolio and enhances its access to the Chinese pharmaceutical market.
EaseMyTrip signed a Memorandum of Understanding with the Department of Tourism, Government of Jharkhand, to promote the state's tourism destinations through digital initiatives and improve visibility among travellers.
Jammu and Kashmir Bank proposed to divest 1.02 crore equity shares, representing a 0.50% stake in PNB MetLife India Insurance Company, to MetLife International Holdings LLC for ₹117.20 per share, aggregating approximately ₹120.1 crore.
Mylan exited Biocon by selling its entire 5.64% stake comprising 9.19 crore shares through block deals valued at ₹3,678.68 crore. Several domestic mutual funds and global institutional investors participated as buyers.
Public Sector Pension Investment Board and Abu Dhabi Investment Authority acquired equity stakes in SG Mart through block deals worth a combined ₹137.98 crore, while HR Global Manufacturing exited part of its holding.
Kusumgar is scheduled to make its debut on the mainboard exchanges today, making it one of the key stocks to watch during the trading session.
Quarterly earnings, strategic investments, regulatory approvals, major partnerships, fresh order wins and listing activity are expected to drive stock-specific movements in today's trading session.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: Jul 15, 2026, 7:49 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN